# Alset Inc.: financial statements, quarterly

AEI · Nasdaq · CIK 1750106 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aei.md) · [Financials](/companies/aei/financials.md) · [Filings](/companies/aei/filings.md) · [Insiders](/companies/aei/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aei/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.0](/filings/0001493152-24-045889.md) | [1.0 d](/filings/0001641172-25-001709.md) | [6.1](/filings/0001641172-25-010947.md) | [1.1](/filings/0001641172-25-024015.md) | [5.0](/filings/0001493152-25-023460.md) | [8.9 d](/filings/0001493152-26-014302.md) | [1.1](/filings/0001493152-26-023104.md) | [1.1](/filings/0001493152-26-038402.md) | [1.0](/filings/0001493152-25-023460.md) | [1.3 d](/filings/0001493152-26-014302.md) | [1.0](/filings/0001493152-26-023104.md) | [1.0](/filings/0001493152-26-038402.md) |
| Cost of revenue | $m | [0.6](/filings/0001493152-24-045889.md) | [1.6 d](/filings/0001641172-25-001709.md) | [4.7](/filings/0001641172-25-010947.md) | [0.8](/filings/0001641172-25-024015.md) | [2.9](/filings/0001493152-25-023460.md) | [4.3 d](/filings/0001493152-26-014302.md) | [0.8](/filings/0001493152-26-023104.md) | [1.0](/filings/0001493152-26-038402.md) | [0.8](/filings/0001493152-25-023460.md) | [0.8 d](/filings/0001493152-26-014302.md) | [0.7](/filings/0001493152-26-023104.md) | [0.9](/filings/0001493152-26-038402.md) |
| Gross profit | $m | [0.4 d](/filings/0001493152-24-045889.md) | [(0.5) d](/filings/0001641172-25-001709.md) | [1.4](/filings/0001641172-25-010947.md) | [0.3 d](/filings/0001641172-25-024015.md) | [2.0 d](/filings/0001493152-25-023460.md) | [4.6 d](/filings/0001493152-26-014302.md) | [0.3](/filings/0001493152-26-023104.md) | [(0.1) d](/filings/0001493152-26-038402.md) | [0.6 d](/filings/0001493152-25-023460.md) | [0.5 d](/filings/0001493152-26-014302.md) | [0.3](/filings/0001493152-26-023104.md) | [0.1 d](/filings/0001493152-26-038402.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(2.1)](/filings/0001493152-24-045889.md) | [(3.8) d](/filings/0001641172-25-001709.md) | [(2.3)](/filings/0001641172-25-010947.md) | [(2.8)](/filings/0001641172-25-024015.md) | [(1.0)](/filings/0001493152-25-023460.md) | [1.9 d](/filings/0001493152-26-014302.md) | [(3.9)](/filings/0001493152-26-023104.md) | [(2.8)](/filings/0001493152-26-038402.md) | [(2.6)](/filings/0001493152-25-023460.md) | [(5.9) d](/filings/0001493152-26-014302.md) | [(2.7)](/filings/0001493152-26-023104.md) | [(1.8)](/filings/0001493152-26-038402.md) |
| Interest expense | $m | not reported | not reported | [0.0](/filings/0001493152-24-019862.md) | [0.1](/filings/0001641172-25-024015.md) | [0.0](/filings/0001493152-25-023460.md) | [0.0 d](/filings/0001493152-26-014302.md) | [0.1](/filings/0001493152-26-023104.md) | [0.0](/filings/0001493152-26-038402.md) | [0.0](/filings/0001493152-25-023460.md) | [(0.1) d](/filings/0001493152-26-014302.md) | [0.0](/filings/0001493152-26-023104.md) | [0.0](/filings/0001493152-26-038402.md) |
| Income tax | $m | [0.0](/filings/0001493152-24-045889.md) | [0.0 d](/filings/0001641172-25-001709.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-023104.md) | [0.0 d](/filings/0001493152-26-038402.md) | [0.0](/filings/0001493152-25-023460.md) | [0.4 d](/filings/0001493152-26-014302.md) | not reported | [0.0](/filings/0001493152-26-038402.md) |
| Net income | $m | [(16.0)](/filings/0001493152-24-045889.md) | [(33.3) d](/filings/0001641172-25-001709.md) | [(6.8)](/filings/0001641172-25-010947.md) | [(1.2)](/filings/0001641172-25-024015.md) | [1.7](/filings/0001493152-25-023460.md) | [2.3 d](/filings/0001493152-26-014302.md) | [(8.3)](/filings/0001493152-26-023104.md) | [(8.2)](/filings/0001493152-26-038402.md) | [1.5](/filings/0001493152-25-023460.md) | [(32.4) d](/filings/0001493152-26-014302.md) | [(4.5)](/filings/0001493152-26-023104.md) | [(5.3)](/filings/0001493152-26-038402.md) |
| Diluted EPS | $ per share | [(1.73)](/filings/0001493152-24-045889.md) | not reported | [(0.73)](/filings/0001641172-25-010947.md) | [(0.13)](/filings/0001641172-25-024015.md) | [0.19](/filings/0001493152-25-023460.md) | not reported | [(0.78)](/filings/0001493152-26-023104.md) | [(0.71)](/filings/0001493152-26-038402.md) | [0.05](/filings/0001493152-25-023460.md) | not reported | [(0.12)](/filings/0001493152-26-023104.md) | [(0.14)](/filings/0001493152-26-038402.md) |
| Basic EPS | $ per share | [(1.73)](/filings/0001493152-24-045889.md) | not reported | [(0.73)](/filings/0001641172-25-010947.md) | [(0.13)](/filings/0001641172-25-024015.md) | [0.19](/filings/0001493152-25-023460.md) | not reported | [(0.78)](/filings/0001493152-26-023104.md) | [(0.71)](/filings/0001493152-26-038402.md) | [0.05](/filings/0001493152-25-023460.md) | not reported | [(0.12)](/filings/0001493152-26-023104.md) | [(0.14)](/filings/0001493152-26-038402.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [28.0](/filings/0001493152-24-045889.md) | [26.9](/filings/0001641172-25-001709.md) | [23.7](/filings/0001641172-25-010947.md) | [18.9](/filings/0001641172-25-024015.md) | [16.7](/filings/0001493152-24-045889.md) | [27.2](/filings/0001493152-26-014302.md) | [25.2](/filings/0001641172-25-010947.md) | [25.6](/filings/0001641172-25-024015.md) | [25.5](/filings/0001493152-25-023460.md) | [25.2](/filings/0001493152-26-038402.md) | [21.5](/filings/0001493152-26-023104.md) | [12.3](/filings/0001493152-26-038402.md) |
| Current assets | $m | [87.7](/filings/0001493152-23-041128.md) | [55.5](/filings/0001641172-25-001709.md) | [48.1](/filings/0001493152-24-019862.md) | [47.9](/filings/0001493152-24-031649.md) | [57.1](/filings/0001493152-24-045889.md) | [59.8](/filings/0001493152-26-014302.md) | [54.1](/filings/0001641172-25-010947.md) | [44.0](/filings/0001641172-25-024015.md) | [44.8](/filings/0001493152-25-023460.md) | [44.8](/filings/0001493152-26-038402.md) | [35.3](/filings/0001493152-26-023104.md) | [30.2](/filings/0001493152-26-038402.md) |
| Total assets | $m | [157](/filings/0001493152-23-041128.md) | [126](/filings/0001641172-25-001709.md) | [96.7](/filings/0001493152-24-019862.md) | [93.5](/filings/0001493152-24-031649.md) | [98.8](/filings/0001493152-24-045889.md) | [96.8](/filings/0001493152-26-014302.md) | [90.5](/filings/0001641172-25-010947.md) | [86.0](/filings/0001641172-25-024015.md) | [169](/filings/0001493152-25-023460.md) | [137](/filings/0001493152-26-038402.md) | [132](/filings/0001493152-26-023104.md) | [125](/filings/0001493152-26-038402.md) |
| Current liabilities | $m | [6.5](/filings/0001493152-23-041128.md) | [8.1](/filings/0001641172-25-001709.md) | [4.6](/filings/0001493152-24-019862.md) | [3.7](/filings/0001493152-24-031649.md) | [3.4](/filings/0001493152-24-045889.md) | [5.5](/filings/0001493152-26-014302.md) | [4.8](/filings/0001641172-25-010947.md) | [4.1](/filings/0001641172-25-024015.md) | [4.2](/filings/0001493152-25-023460.md) | [5.9](/filings/0001493152-26-038402.md) | [3.2](/filings/0001493152-26-023104.md) | [2.5](/filings/0001493152-26-038402.md) |
| Total liabilities | $m | [8.1](/filings/0001493152-23-041128.md) | [9.1](/filings/0001641172-25-001709.md) | [6.7](/filings/0001493152-24-019862.md) | [5.8](/filings/0001493152-24-031649.md) | [5.4](/filings/0001493152-24-045889.md) | [6.6](/filings/0001493152-26-014302.md) | [5.7](/filings/0001641172-25-010947.md) | [4.7](/filings/0001641172-25-024015.md) | [4.7](/filings/0001493152-25-023460.md) | [6.9](/filings/0001493152-26-038402.md) | [4.0](/filings/0001493152-26-023104.md) | [2.8](/filings/0001493152-26-038402.md) |
| Long-term debt | $m | [0.2](/filings/0001493152-23-041128.md) | [0.2](/filings/0001493152-24-012509.md) | [0.1](/filings/0001493152-24-019862.md) | [0.1](/filings/0001493152-24-031649.md) | [0.1](/filings/0001493152-24-045889.md) | [0.1](/filings/0001641172-25-001709.md) | [0.1](/filings/0001641172-25-010947.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [119](/filings/0001493152-23-041128.md) | [88.2](/filings/0001641172-25-001709.md) | [81.7](/filings/0001493152-24-019862.md) | [79.4](/filings/0001493152-24-031649.md) | [84.2](/filings/0001493152-24-045889.md) | [81.3](/filings/0001493152-26-014302.md) | [76.4](/filings/0001641172-25-010947.md) | [72.8](/filings/0001641172-25-024015.md) | [156](/filings/0001493152-25-023460.md) | [121](/filings/0001493152-26-038402.md) | [119](/filings/0001493152-26-023104.md) | [114](/filings/0001493152-26-038402.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.8 d](/filings/0001493152-24-045889.md) | [(0.8) d](/filings/0001641172-25-001709.md) | [(1.5)](/filings/0001641172-25-010947.md) | [(4.4) d](/filings/0001641172-25-024015.md) | [(2.9) d](/filings/0001493152-25-023460.md) | [13.9 d](/filings/0001493152-26-014302.md) | [(3.8)](/filings/0001493152-26-023104.md) | [(2.6) d](/filings/0001493152-26-038402.md) | [0.9 d](/filings/0001493152-25-023460.md) | [(0.4) d](/filings/0001493152-26-014302.md) | [(1.5)](/filings/0001493152-26-023104.md) | [(7.7) d](/filings/0001493152-26-038402.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001493152-24-045889.md) | [0.0 d](/filings/0001641172-25-001709.md) | [0.0](/filings/0001641172-25-010947.md) | [0.0 d](/filings/0001641172-25-024015.md) | [0.0 d](/filings/0001493152-25-023460.md) | [0.0 d](/filings/0001493152-26-014302.md) | [0.1](/filings/0001493152-26-023104.md) | [0.1 d](/filings/0001493152-26-038402.md) | [0.1 d](/filings/0001493152-25-023460.md) | [(0.0) d](/filings/0001493152-26-014302.md) | [0.0](/filings/0001493152-26-023104.md) | [0.1 d](/filings/0001493152-26-038402.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001493152-25-023460.md) | [0.0 d](/filings/0001493152-26-014302.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7.4](/filings/0001493152-23-041128.md) | [8.5](/filings/0001493152-24-019862.md) | [9.2](/filings/0001493152-24-031649.md) | [9.2](/filings/0001493152-24-045889.md) | [9.2](/filings/0001641172-25-010947.md) | [9.2](/filings/0001641172-25-024015.md) | [9.2](/filings/0001493152-25-023460.md) | [10.7](/filings/0001493152-26-023104.md) | [11.6](/filings/0001493152-26-038402.md) | [32.6](/filings/0001493152-25-023460.md) | [38.9](/filings/0001493152-26-023104.md) | [38.9](/filings/0001493152-26-038402.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,895,830 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038402.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.